Replies to post #104826 on Biotech Values

[EyeamBill]

One analyst is projecting peak Gilneya sales of $3.5B, which I think is very doable.

So is there a big pharma play or is this too a drop in the ocean for the big boys?

Is there a big pharma board on iHUB that might be a better one to ask this question than herein?

Bill